Cargando…

The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study

BACKGROUND: Dopamine D2-like receptors are attenuated in aldosterone producing adenoma, lead to overproduction of aldosterone in affected patients, and thus reported to serve as a potential treatment target for primary aldosteronism. The D2 dopamine receptor agonist bromocriptine has been used clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Vin-Cent, Wu, Che-Hsiung, Yang, Ya-Wen, Huang, Kuo-How, Chang, Chia-Hui, Yang, Shao-Yu, Lin, Yen-Hung, Wu, Kwan-Dun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652803/ https://www.ncbi.nlm.nih.gov/pubmed/29100412 http://dx.doi.org/10.18632/oncotarget.20670

Ejemplares similares

Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone
por: Wu, Che-Hsiung, et al.
Publicado: (2015)

Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus
por: Chang, Chia-Hui, et al.
Publicado: (2018)

Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism
por: Wu, Che-Hsiung, et al.
Publicado: (2013)

Risk of sepsis in patients with primary aldosteronism
por: Chan, Chieh-Kai, et al.
Publicado: (2018)

Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population
por: Wu, Vin-Cent, et al.
Publicado: (2015)

Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy
por: Chang, Chia-Hui, et al.
Publicado: (2017)

The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
por: Wu, Vin-Cent, et al.
Publicado: (2017)

Long term outcome of Aldosteronism after target treatments
por: Wu, Vin-Cent, et al.
Publicado: (2016)

Novel Mutations Detection with Next-Generation Sequencing and Its Association with Clinical Outcome in Unilateral Primary Aldosteronism
por: Wu, Che-Hsiung, et al.
Publicado: (2021)

Corrigendum: Long term outcome of Aldosteronism after target treatments
por: Wu, Vin-Cent, et al.
Publicado: (2017)

CTNNB1 Mutation in Aldosterone Producing Adenoma
por: Wang, Jian-Jhong, et al.
Publicado: (2017)

Primary Aldosteronism and Cerebrovascular Diseases
por: Chen, Zheng-Wei, et al.
Publicado: (2018)

Endothelial Dysfunction in Primary Aldosteronism
por: Chen, Zheng-Wei, et al.
Publicado: (2019)

Incidental Congestive Heart Failure in Patients With Aldosterone‐Producing Adenomas
por: Huang, Wei‐Chieh, et al.
Publicado: (2019)

Twenty-Four-Hour Urinary Aldosterone Predicts Inappropriate Left Ventricular Mass Index in Patients with Primary Aldosteronism
por: Hung, Chi-Sheng, et al.
Publicado: (2013)

Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease
por: Wu, Che-Hsiung, et al.
Publicado: (2017)

Reversible heart rhythm complexity impairment in patients with primary aldosteronism
por: Lin, Yen-Hung, et al.
Publicado: (2015)

The relationship among cardiac structure, dietary salt and aldosterone in patients with primary aldosteronism
por: Hung, Chi-Sheng, et al.
Publicado: (2017)

Aldosterone Induced Galectin-3 Secretion In Vitro and In Vivo: From Cells to Humans
por: Lin, Yen-Hung, et al.
Publicado: (2014)

Aldosterone-producing adenoma is associated with urolithiasis in primary aldosteronism
por: Kang, Victor Jing-Wei, et al.
Publicado: (2023)

Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism
por: Cheng, Chung-Yi, et al.
Publicado: (2021)

Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients
por: Liao, Che-Wei, et al.
Publicado: (2016)

Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism
por: Chen, Ying-Ying, et al.
Publicado: (2019)

Evaluation of right adrenal vein anatomy by Dyna computed tomography in patients with primary aldosteronism
por: Lee, Bo-Ching, et al.
Publicado: (2016)

Non-stimulated adrenal venous sampling using Dyna computed tomography in patients with primary aldosteronism
por: Chang, Chin-Chen, et al.
Publicado: (2016)

Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score–Matching Follow‐Up Study With Tissue Doppler Imaging
por: Chang, Yi‐Yao, et al.
Publicado: (2019)

Editorial: Diagnosis and Treatment of Primary Aldosteronism: from Clinical Origin to Translational Research
por: Wu, Wan-Chen, et al.
Publicado: (2021)

The Relationship Between Renal Stones and Primary Aldosteronism
por: Chang, Chun-Kai, et al.
Publicado: (2022)

The Association between Glomerular Hyperfiltration and Left Ventricular Structure and Function in Patients with Primary Aldosteronism
por: Liao, Min-Tsun, et al.
Publicado: (2015)

Influence of autonomous cortisol secretion in patients with primary aldosteronism: subtype analysis and postoperative outcome
por: Hung, Kuang, et al.
Publicado: (2023)

Plasma Aldosterone Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive Patients for Atherosclerotic Cardiovascular Disease
por: Lin, Jui-Hsiang, et al.
Publicado: (2018)

Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism
por: Lin, Yu-Fang, et al.
Publicado: (2020)

Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology
por: Chen, Yi-Ju, et al.
Publicado: (2022)

Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism
por: Chang, Yi-Yao, et al.
Publicado: (2023)

Who should be screened for primary aldosteronism? A comprehensive review of current evidence
por: Huang, Wei‐Chieh, et al.
Publicado: (2022)

Aldosterone Suppresses Endothelial Mitochondria through Mineralocorticoid Receptor/Mitochondrial Reactive Oxygen Species Pathway
por: Peng, Shih-Yuan, et al.
Publicado: (2022)

Mineralocorticoid receptor antagonist treatment improved arterial stiffness in patients with primary aldosteronism: a cohort study compared with adrenalectomy
por: Liao, Che-Wei, et al.
Publicado: (2023)

GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism
por: Wu, Yu-Ching, et al.
Publicado: (2022)

Anatomical and functional remodeling of left ventricle in patients with primary aldosteronism and concomitant albuminuria
por: Kao, Ting-Wei, et al.
Publicado: (2023)

Aldosterone Excess Induced Mitochondria Decrease and Dysfunction via Mineralocorticoid Receptor and Oxidative Stress In Vitro and In Vivo
por: Tsai, Cheng-Hsuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gme88r3234vvhrk4fmm08rqi7p